---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-23-001812"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2023-10-12T23:59:59+00:00"
generated_at: "2026-06-10T00:35:07.957702+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lexaria shareholders approve reverse stock split; company granted two Canadian patents

## Summary
- Shareholders approved reverse stock split with ratio between 2:1 and 12:1 (67% for).
- Entered 3-month investor relations contract with Andrew Barwicki Inc. for $99,500.
- Granted Canadian patent for DehydraTECH in ready-to-drink beverages (expires Dec 2036).
- Granted Canadian patent for tobacco leaves infused with lipophilic agents (expires Sep 2039).
- Total granted patents now 37 worldwide.

## SEC filing metadata
- accession: 0001640334-23-001812
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2023-10-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033423001812/0001640334-23-001812-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033423001812/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-23-001812
- JSON: https://secwatch.observer/filing/0001640334-23-001812.json
- Plain text: https://secwatch.observer/filing/0001640334-23-001812.txt

## Key facts
- Shareholder Votes
  Lexaria Bioscience Corp. shareholders approved To approve a reverse stock split with such ratio to be not less than 2 current shares for one post reverse stock split share and no more than 12 current shares for one post reverse stock split. at the 2023-10-10 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2023-10-10
  source text: Matter Being Voted On For Against/ Withheld Abstain Broker Non-Vote Percent Approved By 1 To Approve a Reverse Stock Split with such ratio to be not less than 2 current shares for one post reverse stock split share and no more than 12 current shares for one post reverse stock split. 3,120,754 1,546,507 13,453 0 67 %
  evidence_url: https://www.sec.gov/Archives/edgar/data/1348362/000164033423001812/0001640334-23-001812-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.